产品编号:A112425
产品规格:50mg
产品价格:面议
| 标准品编号: | A112425 |
| 名称: | ABT 199 (>99%)(Venetoclax) |
| 别名: | 4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide |
| CAS号: | 1257044-40-8 |
| 分子式: | C₄₅H₅₀ClN₇O₇S |
| 状态: | 淡黄色固体 |
| 熔点: | >150°C (dec.) |
| 分子量: | 868.44 |
| 储存: | -20°C Freezer |
| 溶解性: | DMSO (Slightly) |
| 类别: | Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | ABT 199 (>99%) is a potent and selective BCL-2 inhibitor that achieves potent antitumour activity while sparing platelets. It’s practical application is to treat chronic lymphocytic leukaemic cells and estrogen receptor-positive breast cancer. |
| 参考: | |